Using an innovative approach to identify a cancer’s genetic vulnerabilities by more swiftly analyzing human tumors transplanted into mice, researchers have identified a new potential target for pancreatic cancer treatment, published online in Cell...
23-Jun-2016 11:05 AM EDT Add to Favorites
The University of Texas MD Anderson Cancer Center will join institutions across the country in the inaugural national Cancer Moonshot Summit, convened at the request of Vice President Joe Biden, on June 29.
21-Jun-2016 9:05 AM EDT Add to Favorites
Early-stage breast cancer patients receiving a shorter course of whole breast radiation with higher radiation doses per fraction reported equivalent cosmetic, functional and pain outcomes over time as those receiving a longer, lower-dose per...
15-Jun-2016 9:05 AM EDT Add to Favorites
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell...
10-Jun-2016 2:05 PM EDT Add to Favorites
MD Anderson and Bristol-Myers Squibb Announce New Research Collaboration in Immuno-Oncology Focused on Lung Cancer
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a new clinical research collaboration to evaluate innovative strategies for the potential use of Bristol-Myers Squibb’s immuno-oncology agents...
7-Jun-2016 9:05 AM EDT Add to Favorites
Progression-Free Survival Triples in Select Metastatic Lung Cancer Patients with Surgery or Radiation After Standard Chemotherapy
Lung cancer patients with oliogometastases, defined as three or fewer sites of metastasis, may benefit from aggressive local therapy, surgery or radiation, after standard chemotherapy, according to research led by The University of Texas MD Anderson...
3-Jun-2016 3:05 PM EDT Add to Favorites
Advances that could change gynecologic cancer standard–of-care treatments are the centerpiece of key studies being presented by researchers from The University of Texas MD Anderson Cancer Center’s Department of Gynecologic Oncology and...
3-Jun-2016 2:05 PM EDT Add to Favorites
The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless of whether their tumors had a biomarker related to the drug’s target, according to clinical trial results...
5-Jun-2016 9:00 AM EDT Add to Favorites
It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT
Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT
A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT
MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System
The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT
Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST
30-Oct-2013 8:10 PM EDT
30-Oct-2013 8:00 PM EDT
Expert at The University of Texas M. D. Anderson Cancer Center provide insight to parents based on what we've learned about about the HPV vaccine in the past four years.
12-Jan-2010 3:45 PM EST